Clinical Trials in Minneapolis

Showing 14061-14080 of 14,456 trials

COMPLETEDPhase 1< 1 mile

Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)

NCT00002036

To investigate the potential benefit of providing passive immunity with hyperimmune anti-HIV human serum.

HIV Infections

Abbott12 participants

Minneapolis, Minnesota, United States

COMPLETEDPhase 2< 1 mile

CPG 7909 Injection in Non-Small Cell Lung Cancer

NCT00070629

Eligible patients will be randomized in a ratio of 2:1 to receive either chemotherapy (a taxane and a platinum compound) plus CPG 7909 Injection or chemotherapy alone. Protocol therapy will be administered until disease progression or intolerable toxicity. CpG 7909 Injection will be administered subcutaneously, on Weeks 2 and 3 of each three-week cycle (days 8 and 15) and chemotherapy will be administered on Week 1 (Day 1). Patients will undergo complete disease evaluation at the end of every other treatment cycle until disease progression.

Carcinoma, Non-Small Cell Lung

Pfizer116 participantsStarted May 2003

Gilroy, California, United States • Los Angeles, California, United States • Palm Springs, California, United States +21 more locations

Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)

CPG 7909 Injection in Non-Small Cell Lung Cancer

Find Trials by Condition in Minneapolis

An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients

ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

Study of Weight Loss Using Gastric Stimulation in Obese Patients With Type 2 Diabetes

Lofexidine for Inpatient Opiate Detox

A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee

BST-DERMON Versus Standard of Care in the Treatment of Diabetic Foot Ulcers

A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C

Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis

Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)

MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology

Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer

Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)

Canadian, Multi-Centre Study of Symptom Burden and Clinical Management in Subjects With GERD

Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)

The Oscillation for ARDS Treated Early (OSCILLATE) Trial Pilot Study

Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients

Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients

A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder